OctoPlus wins manufacturing contract from French-based biotechnology company
OctoPlus N.V. announced that it has signed a pharmaceutical manufacturing contract with an existing client, a French-based biotechnology company. The undisclosed contract value will make a material contribution to OctoPlus' annual revenues.
Under the contract terms, OctoPlus will perform clinical manufacturing for the client's product candidate.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Affymetrix and Empire Genomics Enter Into Licensing Agreement

Pain relief without side effects and addiction - Better than opiates: Researchers use adrenaline receptors for highly-effective analgesics

Looking for Start-up (ideas) in chemical engineering, chemistry and biotechnology - ACHEMA Start-Up Award
Endotis reports the successful completion of Phase I clinical trials of neutralizable anticoagulant EP217609 and antidote avidin
